BR112017012810A2 - method for treating or preventing diseases associated with air pollution - Google Patents

method for treating or preventing diseases associated with air pollution

Info

Publication number
BR112017012810A2
BR112017012810A2 BR112017012810-1A BR112017012810A BR112017012810A2 BR 112017012810 A2 BR112017012810 A2 BR 112017012810A2 BR 112017012810 A BR112017012810 A BR 112017012810A BR 112017012810 A2 BR112017012810 A2 BR 112017012810A2
Authority
BR
Brazil
Prior art keywords
air pollution
treating
diseases associated
preventing diseases
subjects
Prior art date
Application number
BR112017012810-1A
Other languages
Portuguese (pt)
Chinese (zh)
Inventor
Zhang Weiguo
He Qing
Chen Jiong
L. Eggersdorfer Manfred
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of BR112017012810A2 publication Critical patent/BR112017012810A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A method for treatment and prevention of air pollution-related diseases, especially diseases related to atmospheric PM2.5 in subjects. The method comprises administering an effective amount of a polyunsaturated fatty acid and vitamin E to subjects in need thereof.
BR112017012810-1A 2014-12-15 2015-12-14 method for treating or preventing diseases associated with air pollution BR112017012810A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201410777679 2014-12-15
CN201410777679.5 2014-12-15
PCT/CN2015/097277 WO2016095778A1 (en) 2014-12-15 2015-12-14 Method for treatment and prevention of air pollution-related diseases

Publications (1)

Publication Number Publication Date
BR112017012810A2 true BR112017012810A2 (en) 2018-04-10

Family

ID=56125926

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017012810-1A BR112017012810A2 (en) 2014-12-15 2015-12-14 method for treating or preventing diseases associated with air pollution

Country Status (3)

Country Link
CN (1) CN107106535A (en)
BR (1) BR112017012810A2 (en)
WO (1) WO2016095778A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021005813A2 (en) * 2018-09-26 2021-06-29 Amarin Pharmaceuticals Ireland Limited compositions and methods for treating or preventing diseases and/or disorders caused by exposure to air pollution
BR112021007396A2 (en) 2018-10-22 2021-08-03 Dsm Ip Assets B.V. composition that exhibits improved oxidative stability

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101611862A (en) * 2008-06-26 2009-12-30 威海清华紫光科技开发有限公司 The preparation of water soluble pearl powder and method for producing soft capsule

Also Published As

Publication number Publication date
WO2016095778A1 (en) 2016-06-23
CN107106535A (en) 2017-08-29

Similar Documents

Publication Publication Date Title
CL2018001349A1 (en) Compositions comprising bacterial strains
CL2018001367A1 (en) Compositions comprising bacterial strains
DOP2016000109A (en) SOLID FORMS OF ACID {[5- (3-CHLOROPHENYL) -3-HYDROXIPIRIDIN-2-CARBON] AMINO} ACETIC, COMPOSITIONS, AND USES OF THE SAME.
PH12017501611A1 (en) Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
CL2018002814A1 (en) Compositions and methods for the treatment of wounds, disorders, and skin diseases.
IL255203B (en) Topical pharmaceutical emulsion compositions comprising 3,5-dihydroxy-4-isopropyl-trans-stilbene and use thereof in the treatment or prophylaxis of dermatological conditions or disorders
WO2015077503A8 (en) Autotaxin inhibitor compounds
MX2019015311A (en) Cannabidiolic acid esters compositions and uses thereof.
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
BR112018005905A2 (en) ? compound, pharmaceutical composition, methods to prevent or treat a disease or condition, organ damage, hepatotoxicity and fatty liver, and, use of a compound?
CY1123942T1 (en) OMEGA-3 FATTY ACID COMPOSITIONS FOR THE TREATMENT OF DISEASES CAUSING DAMAGE TO THE NERVOUS SYSTEM
WO2014106825A3 (en) Methods and devices for identifying improper medical reporting
MX2019003703A (en) Safe and effective method of treating psoriasis with anti-il23 specific antibody.
MX2016015211A (en) Topical formulations and uses thereof.
BR112017028468A2 (en) solid oral formulation, and method for preparing a solid oral formulation
PH12016501371A1 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
EP4356962A3 (en) Selective il-6-trans-signalling inhibitor compositions
BR112017005272A2 (en) cysteamine to treat yeast / mold infections
BR112017026834A2 (en) [Use of the inventive name established by ISA under Rule 37.2] The use of a complex vitamin composition for the preparation of a medicament for promoting gastrointestinal motility
BR112017011685A2 (en) compositions comprising 15-hepe and methods of treating or preventing fibrosis using the same
BR112015024703A2 (en) pharmaceutical formulation, method of treatment and / or prevention of restenosis and kit for the treatment and / or prevention of restenosis
BR112014024033A8 (en) VESICULAR FORMULATION, METHOD FOR THE TREATMENT OF ROSACEA AND USE OF ONE OR MORE PHOSPHO, SULPHOLIPIDS AND SURFACTANTS
BR112017012810A2 (en) method for treating or preventing diseases associated with air pollution
EP3344233A4 (en) Transdermal formulations for delivery of doxycycline, and their use in the treatment of doxycycline-responsive diseases and conditions
WO2017079403A3 (en) Polymeric nanoparticles

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]